Dvago Logo
    location icon

    Dvago Logo

    Delivers in

      location icon

      stir-up tablets 10mg (1 strip = 10 tablets) Product Image

      Stir-Up Tablets 10Mg (1 Strip = 10 Tablets)

      Rs. 456.00

      Rs. 480.00



      Stir-Up Tablets Specification

      Requires Prescription (YES/NO)



      Memantine Hydrochloride

      Used For


      How it works

      There is evidence that malfunctioning of glutamatergic neurotransmission, in particular at N-methyl-D-aspartate (NMDA)-receptors, contributes to both expression of symptoms and disease progression in neurodegenerative dementia. Memantine is a voltage-dependent, moderate-affinity uncompetitive NMDA-receptor antagonist. It blocks the effects of pathologically elevated tonic levels of glutamate that may lead to neuronal dysfunction .

      Stir-Up Tablets Usage And Safety


      Memantine Hydrochloride

      Side Effects

      Common: Headache, sleepiness, constipation, elevated liver function test, dizziness, balance disorders, shortness of breath, high blood pressure and drug hypersensitivity ; Uncommon: Tiredness, fungal infections, confusion, hallucinations, vomiting, abnormal gait, heart failure and venous blood clotting (thrombosis/thromboembolism).

      Drug Interactions

      L-dopa, dopaminergic agonists, and anticholinergics , antispasmodic medicines, dantrolene or baclofen , amantadine , cimetidine, ranitidine, procainamide, quinidine, quinine and nicotine , hydrochlorothiazide (HCT) , dextromorphan , oral anticoagulants .


      Treatment of patients with moderately severe to severe Alzheimer’s disease .

      When not to Use

      Hypersensitivity to memantine hydrochloride or to any of the excipients . Children and adolescents below the age of 18 years, as safety and efficacy have not been established.

      Stir-Up Tablets Precautions


      Based on pharmacological considerations and single case reports, caution is recommended with patients suffering from epilepsy.

      Stir-Up Tablets Warnings

      Warning 1

      Concomitant use of N-methyl-D-aspartate (NMDA)-antagonists such as amantadine, ketamine or dextromethorphan should be avoided. These medicines act at the same receptor system as this product and therefore adverse drug reactions (mainly CNS-related) may be more frequent or more pronounced .

      Warning 2

      In most clinical trials with Memantine, patients with recent myocardial infarction, congestive heart failure (NYHA III-IV) and uncontrolled hypertension were excluded. As a consequence only limited data are available and patients with these conditions should be closely supervised.

      Warning 3

      Moderately severe to severe Alzheimer’s disease usually causes impairment of driving performance and compromises the ability to use machinery. Furthermore, Memantine may change reactivity such that outpatients should be warned to take special care when driving a vehicle or operating machinery.

      Stir-Up Tablets Additional Information

      Pregnancy category

      Always consult your physician before using any medicine.

      Storage (YES/NO)

      Store this medicine at room temperature, away from direct light and heat.

      Related Products